Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.
2.

Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants.

Simon GE, VonKorff M, Heiligenstein JH, Revicki DA, Grothaus L, Katon W, Wagner EH.

JAMA. 1996 Jun 26;275(24):1897-902.

PMID:
8648870
3.

Effectiveness of an intervention led by lay health counsellors for depressive and anxiety disorders in primary care in Goa, India (MANAS): a cluster randomised controlled trial.

Patel V, Weiss HA, Chowdhary N, Naik S, Pednekar S, Chatterjee S, De Silva MJ, Bhat B, Araya R, King M, Simon G, Verdeli H, Kirkwood BR.

Lancet. 2010 Dec 18;376(9758):2086-95. doi: 10.1016/S0140-6736(10)61508-5. Epub 2010 Dec 13.

4.

Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial.

Sacristán JA, Gilaberte I, Boto B, Buesching DP, Obenchain RL, Demitrack M, Pérez Sola V, Alvarez E, Artigas F.

Int Clin Psychopharmacol. 2000 Mar;15(2):107-13.

PMID:
10759342
5.

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.

Pérez V, Gilaberte I, Faries D, Alvarez E, Artigas F.

Lancet. 1997 May 31;349(9065):1594-7.

PMID:
9174562
6.

Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.

Kroenke K, West SL, Swindle R, Gilsenan A, Eckert GJ, Dolor R, Stang P, Zhou XH, Hays R, Weinberger M.

JAMA. 2001 Dec 19;286(23):2947-55.

PMID:
11743835
7.

Fluoxetine versus other types of pharmacotherapy for depression.

Cipriani A, Brambilla P, Furukawa T, Geddes J, Gregis M, Hotopf M, Malvini L, Barbui C.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004185. Review. Update in: Cochrane Database Syst Rev. 2013;7:CD004185.

8.

Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder.

Snedecor SJ, Botteman MF, Schaefer K, Sarocco P, Barry N, Pickard AS.

J Ment Health Policy Econ. 2010 Mar;13(1):27-35.

PMID:
20571180
9.
10.

Second-generation antidepressants for seasonal affective disorder.

Thaler K, Delivuk M, Chapman A, Gaynes BN, Kaminski A, Gartlehner G.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD008591. doi: 10.1002/14651858.CD008591.pub2. Review.

PMID:
22161433
12.

Effectiveness and cost-effectiveness of antidepressant treatment in primary health care: a six-month randomised study comparing fluoxetine to imipramine.

Serrano-Blanco A, Gabarron E, Garcia-Bayo I, Soler-Vila M, Caramés E, Peñarrubia-Maria MT, Pinto-Meza A, Haro JM; Depressió en Atenció Primària de Gavà Group (D. A. P. G. A.).

J Affect Disord. 2006 Apr;91(2-3):153-63. Epub 2006 Feb 3.

PMID:
16458976
13.

Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial.

Domino ME, Foster EM, Vitiello B, Kratochvil CJ, Burns BJ, Silva SG, Reinecke MA, March JS.

J Am Acad Child Adolesc Psychiatry. 2009 Jul;48(7):711-20. doi: 10.1097/CHI.0b013e3181a2b319.

PMID:
19465880
14.

Pharmacological interventions for somatoform disorders in adults.

Kleinstäuber M, Witthöft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ.

Cochrane Database Syst Rev. 2014 Nov 7;11:CD010628. doi: 10.1002/14651858.CD010628.pub2. Review.

PMID:
25379990
15.

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.

16.
18.

Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults.

Williams JW Jr, Barrett J, Oxman T, Frank E, Katon W, Sullivan M, Cornell J, Sengupta A.

JAMA. 2000 Sep 27;284(12):1519-26.

PMID:
11000645
19.

The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review.

Rodgers M, Asaria M, Walker S, McMillan D, Lucock M, Harden M, Palmer S, Eastwood A.

Health Technol Assess. 2012 May;16(28):1-130. doi: 10.3310/hta16280. Review.

20.

The feasibility of a randomised, placebo-controlled clinical trial of homeopathic treatment of depression in general practice.

Katz T, Fisher P, Katz A, Davidson J, Feder G.

Homeopathy. 2005 Jul;94(3):145-52.

PMID:
16060200
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk